15.80
前日終値:
$16.05
開ける:
$16.07
24時間の取引高:
114.67K
Relative Volume:
0.68
時価総額:
$431.38M
収益:
$56.44M
当期純損益:
$-32.60M
株価収益率:
-12.83
EPS:
-1.2318
ネットキャッシュフロー:
$-35.15M
1週間 パフォーマンス:
+14.66%
1か月 パフォーマンス:
+46.30%
6か月 パフォーマンス:
+20.98%
1年 パフォーマンス:
+21.17%
Carlsmed Inc Stock (CARL) Company Profile
Compare CARL vs VEEV, TEM, BTSG, HQY, TXG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CARL
Carlsmed Inc
|
15.80 | 450.50M | 56.44M | -32.60M | -35.15M | -1.2318 |
|
VEEV
Veeva Systems Inc
|
248.46 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
66.17 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
59.49 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
105.40 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
63.80 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-18 | 開始されました | BTIG Research | Buy |
| 2025-08-18 | 開始されました | BofA Securities | Buy |
| 2025-08-18 | 開始されました | Goldman | Buy |
| 2025-08-18 | 開始されました | Piper Sandler | Overweight |
| 2025-08-18 | 開始されました | Truist | Buy |
Carlsmed Inc (CARL) 最新ニュース
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Carlsmed (CARL) Stock Revenue Surge Meets A Wider Loss Per Share - Sahm
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com
Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionSeasonality Effect - dars.gov.et
Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ... - Yahoo Finance UK
Carlsmed Q2 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingView
Carlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingView
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - The Manila Times
Carlsmed, Inc. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Carlsmed, Inc. $CARL Stock Holdings Lifted by Janus Henderson Group PLC - MarketBeat
Carlsmed (CARL) Earnings Date and Reports 2026 $CARL - MarketBeat
Carlsmed (CARL) Gains Favorable CMS Reimbursement Policy Boostin - GuruFocus
Carlsmed, Inc. expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures - The Manila Times
Carlsmed Inc. (CARL) Holds Near $12.59 as Support and Resistance Levels TightenSmart Money Flow Stocks - dars.gov.et
Will Carlsmed, Inc. (CARL) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
CARL|Carlsmed Ord Shs|Price:10.800|Chg%:-0.200 - TradingKey
Carlsmed Inc. (CARL) Declines Slightly as Stock Nears Key Support LevelBox Spread - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Carlsmed Inc. (CARL) Q1 2026 Earnings: EPS Beat Provides Cautious Optimism Amid Ongoing Market VolatilityRevenue Per Share - dars.gov.et
KCM Capital Inc Invests $1.81 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed Inc. (CARL) Slips 1.72% as Stock Tests Support LevelsContinuation Pattern Picks - dars.gov.et
Carlsmed to report Q2FY26 results on August 5, 2026 - scanx.trade
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 - marketscreener.com
Carlsmed Inc. (CARL) Slips Over 2.8% as Resistance Holds Near $11.90Short Setup Alerts - dars.gov.et
Carlsmed Inc. Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Medtech Advances Personalized Spine PlatformSurprise Factor Analysis - dars.gov.et
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
Carlsmed Inc. (CARL) Q1 2026 Earnings: EPS Surpasses Estimates as Pre-Revenue Company Advances Development - dars.gov.et
Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m - 富途牛牛
Gross profit of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed Inc. (CARL) Slips 3.16% as Stock Trades Near Key Support LevelLiquidity Order Flow - po-news-eg.net
Carlsmed (CARL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CARL Initiates Coverage On Needham -- Rating Set to Buy - GuruFocus
Carlsmed Inc (CARL) 財務データ
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
大文字化:
|
ボリューム (24 時間):